Marc Beer is a graduate from Miami University where he pursued BS; upon graduation, Marc Beer joined the health sector where he has made significant contributions. He has worked in various companies providing a change in the management and services provided to patients. For over 25 years Marc Beer has earned extensive skills and knowledge as a leader and information on the health sector. Marc Beer has served at the top executive positions in various companies including; OvaScience, ViaCell, Aegerion, Skulpt, Minerva Neuroscience among others. He has ensured to create change by transforming the management and marketing strategies. Marc Beer has shown remarkable leadership skills; hence multiple organizations have given him the mandate to be the chairperson for their board of directors to share his insight on the necessary changes to be made in the company. Some of these companies include; Good Start Genetics, ERYtech, Minerva Neuroscience among others.
Marc Beer is the co-founder of Renovia company that established and completed the Series A project successfully; he is the CEO hence has the responsibility of making various significant decisions regarding technology and management decisions. Marc Beer has overseen the establishment of Leva device which has been designed by experts to serve several purposes. The leva device is fitted with a sensor technology which shows that representation of the virginal and the movement of pelvic muscles; it’s able to detect where the pelvic floor muscles have loosened hence starts training them and rehabilitating. Marc Beer is concerned with the health of women; hence he has raised $42 million to construct a modern medical center in Boston. They will hire experts to research new treatment methods for pelvic disorders including the Urinary incontinence and other diseases caused by physical movements including stress placed on the bladder.
Marc Beer will be able to market the Leva Device through the Boston based medical center which has adopted modern sensor proprietary technology to provide high standard services to thousands of patients across the globe. The idea to start the Series B project was inspired by the researcher’s report which stated that more than 250 million women suffer from pelvic disorders but cannot afford treatments since other centers offer expensive services. He has partnered with Western Technologies, Longwood fund among other health-related organizations to ensure that they create awareness to millions of people on pelvic disorders by establishing a digital platform where people can get necessary skills and knowledge on how they can solve pelvic disorders problems.
Marc Beer contributions to the health industry have given hope to millions on women by providing treatments that are more efficient and have no side effects. He works closely with other top leaders to ensure the smooth running of the company. Learn more: https://renoviainc.com/leadership/
Pelvic floor disorder, a condition present mostly in women who have already experienced giving birth, affects 250 million plus women worldwide. Scientists are trying to understand why a lot of women are affected, and they are also trying to generate a treatment that would allow those who are affected with the condition to live normal lives. Private individuals are also doing their part to prevent the spread of the condition, and to help those who are suffering from pelvic floor disorders. One of them is Marc Beer, who is an American businessman known as the mind behind the establishment of Renovia Inc. The company that he founded focuses on the creation of treatment options for people who are diagnosed with pelvic floor disorders. According to Marc Beer, Renovia Inc. has a huge success rate for developing a new treatment against pelvic floor disorders, and the company is currently conducting research on how they could develop a treatment for other diseases that mostly affect the female population.
Marc Beer has extensive experience in the medical sector, and he used his connections to establish his own company that would focus on the prevention of diseases that mostly target women. His company, which is headquartered in the city of Boston, receives a lot of investment of third-party entities. One of the most recent funding that Marc Beer secured came from a group of investors who lend him $42 million. The money that they raised will be used in research, and some will be spent on the production of treatments. Marc Beer did not expect that his business partners will be helping him extensively in running the company, and he said that he will continue producing great results from the research that he became a part of.
Through continuous experimentation, Renovia Inc. was able to create a product known to minimize the effects of pelvic floor disorders. The company dubbed the product as Leva, which was released recently in the market. The product came under strict inspection and testing from the Food and Drug Administration, and they only released the documents for the product last April 2018. They said that Renovia Inc. managed to pass their checklist, and they will be giving them a permit to operate and sell the products that they manufacture. Marc Beer thanked their business partners for their continued support. The Longwood Fund, which is a major donor of money used in Renovia Inc.’s research, said that helping the company is worth it because they are trying to change the future for the benefit of everyone living in it. Marc Beer is optimistic about the opportunities coming back and forth, and he said that he will be doing everything that he can to help the business grow. His company is also investing in marketing services, which will increase the public’s perception of his company. Learn more: https://renoviainc.com/
Many women feel that their health concerns are not being adequately addressed. Fortunately, there have been some big changes when it comes to healthcare with entrepreneurs like Marc Beer working to treat and diagnose health problems that impact women. He has led companies in the healthcare industrybefore, but his most recent project is Renovia. Renovia focuses on the development of products for women with pelvic floor disorder. The company is based out of the Boston area and was founded in 2016 by Marc Beer who is their Chairman and Chief Executive Officer.
During their first round of funding, Renovia was able to raise an impressive amount of capital under the leadership of Marc Beer. With this money, they were able to get one of their products approved by the Food and Drug Administration already with several more in different levels of the development process. The second round of funding raised total funding for $42 million. Encouraged by the progress made by the company already, some of the investors that had been part of the company’s early funding returned for the second round.
Many of the Renovia investors are leaders in the healthcare investment industry. Marc Beer is excited about having their support and believes that they will help him change the lives of millions of women with pelvic floor disorder. The disorder is uncomfortable and in some cases, it can even be painful. It’s a disorder that Marc Beer believes has a lot of room for progress in order to improve the quality of life for these women suffering from pelvic floor disorder around the world. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html
The devices produced by Renovia have sensors embedded into them that use proprietary technology that is truly state of the art. This will help researchers and physicians know more about the condition and also allow patients to track their data using an app. Marc Beer and Renovia will be using this funding to create a newer version of their device that had previously been approved by the Food and Drug Administration along with other products that are targeted towards the treatment of pelvic floor disorder along with diagnostic devices.
With a decade and a half of experience under his belt in different health care industries, Marc Beer is well known on Wall Street for his work. He has worked with the diagnostic, pharmaceutical, biotechnology sectors during his career and continues to do so to this day. In addition to his responsibilities at Renovia, he is also involved with 2 other companies as well. Marc Beer serves as a Chairman for both Good Start Genetics and Minerva Biosciences since 2010 and 2013.